<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Health care / Health / Pharmaceutical industry / Medical research / Healthcare quality / European Medicines Agency / European Union / Qualified Person Responsible For Pharmacovigilance / Marketing authorization / Summary of Product Characteristics / Pharmacovigilance
Date: 2016-02-02 09:57:36
Pharmaceuticals policy
Health care
Health
Pharmaceutical industry
Medical research
Healthcare quality
European Medicines Agency
European Union
Qualified Person Responsible For Pharmacovigilance
Marketing authorization
Summary of Product Characteristics
Pharmacovigilance

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 225,29 KB

Share Document on Facebook

Similar Documents

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

DocID: 1rcFm - View Document

COMMISSION OF THE EUROPEAN COMMUNITIES  Brussels, 10 December 2008 SECVolume I

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

DocID: 1qH6O - View Document

Better vigilance for health health protection protection and and innovation

Better vigilance for health health protection protection and and innovation

DocID: 1q6Mb - View Document

Microsoft Word - Volume IX ENdoc

Microsoft Word - Volume IX ENdoc

DocID: 1g2y9 - View Document

Pharmacology / Health / Notary / Drug safety / Qualified Person Responsible For Pharmacovigilance / Marketing authorization / Pharmacovigilance / Public key certificate / Pharmaceuticals policy / Pharmaceutical sciences / Pharmaceutical industry

Name of medicinal product: Procedure number: Module 1: PL=RMS

DocID: 1fB8i - View Document